107 related articles for article (PubMed ID: 1755378)
1. Formation and biological properties of neutrophil activating peptide 2 (NAP-2).
Walz A; Zwahlen R; Baggiolini M
Adv Exp Med Biol; 1991; 305():39-46. PubMed ID: 1755378
[No Abstract] [Full Text] [Related]
2. Generation and properties of neutrophil-activating peptide 2.
Walz A
Cytokines; 1992; 4():77-95. PubMed ID: 1472918
[No Abstract] [Full Text] [Related]
3. A novel molecular variant of the neutrophil-activating peptide NAP-2 with enhanced biological activity is truncated at the C-terminus: identification by antibodies with defined epitope specificity.
Brandt E; Petersen F; Flad HD
Mol Immunol; 1993 Aug; 30(11):979-91. PubMed ID: 7688853
[TBL] [Abstract][Full Text] [Related]
4. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
Walz A; Baggiolini M
Biochem Biophys Res Commun; 1989 Mar; 159(3):969-75. PubMed ID: 2522778
[TBL] [Abstract][Full Text] [Related]
5. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
Walz A; Baggiolini M
J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
[TBL] [Abstract][Full Text] [Related]
6. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
[TBL] [Abstract][Full Text] [Related]
7. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
Ehlert JE; Petersen F; Kubbutat MH; Gerdes J; Flad HD; Brandt E
J Biol Chem; 1995 Mar; 270(11):6338-44. PubMed ID: 7890771
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
Power CA; Proudfoot AE; Magnenat E; Bacon KB; Wells TN
Eur J Biochem; 1994 Apr; 221(2):713-9. PubMed ID: 7513641
[TBL] [Abstract][Full Text] [Related]
9. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.
Walz A; Burgener R; Car B; Baggiolini M; Kunkel SL; Strieter RM
J Exp Med; 1991 Dec; 174(6):1355-62. PubMed ID: 1744577
[TBL] [Abstract][Full Text] [Related]
10. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
11. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
[TBL] [Abstract][Full Text] [Related]
12. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
13. Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).
Kungl AJ; Machius M; Huber R; Schwer C; Lam C; Aschauer H; Ehn G; Lindley IJ; Auer M
FEBS Lett; 1994 Jun; 347(2-3):300-3. PubMed ID: 8034022
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
15. [Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA.
Walz A; Meloni F; Clark-Lewis I; von Tscharner V; Baggiolini M
J Leukoc Biol; 1991 Sep; 50(3):279-86. PubMed ID: 1856598
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
Yan Z; Holt JC; Stewart GJ; Niewiarowski S
Am J Physiol; 1993 Nov; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
[TBL] [Abstract][Full Text] [Related]
17. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
Ehlert JE; Gerdes J; Flad HD; Brandt E
J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
Schröder JM; Persoon NL; Christophers E
J Exp Med; 1990 Apr; 171(4):1091-100. PubMed ID: 2182761
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release.
Petersen F; Van Damme J; Flad HD; Brandt E
Lymphokine Cytokine Res; 1991 Apr; 10(1-2):35-41. PubMed ID: 1651769
[TBL] [Abstract][Full Text] [Related]
20. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
Van Osselaer N; Van Damme J; Rampart M; Herman AG
Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
